@hiddensmallcaps @humour_humourrr $ARWR has a LONG way to run, extremely undervalued. Each item in pipe could be worth at least the current marketcap as a standalone. 10 drugs in clinic by year end, ~20 expected by end of 2022. $JNJ moving fast on ARWR #HBV trials &amp; 3 options identified. #COVID19 #RNAi as well